| NCT Number | NCT07537179 |
| Lead Sponsor | Oguz Gundogdu |
| Conditions | Sepsis, Intensive Care (ICU), Acute Phase Biomarkers |
| Enrollment | 120 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2023-12-30 (estimated) |
| Study Completion | 2024-01-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-04-17 |